The Little Giant refines into a | "health sentinel" to guard patients near and far

Little Giant Refining Memories - Searching for Specialized New SMEs 9 Golden Mile Medicine

Keywords: international advanced

On the afternoon of April 2, at a hospital in Xiangzhou District, Zhuhai, Ms. Zhang, 34, was undergoing surgery to remove the ovarian mass on her left side. Materials, slices, stains, scans... Within minutes, the patient's digital pathology picture was generated into a 3G-sized file and uploaded to the Golden Mile Remote Digital Pathology Platform system.

Jinyu Medicine provides hundreds of millions of accurate diagnosis services for the Chinese people every year, which is the third-party medical laboratory group with the largest scale, the widest service network, the most international certification and the most complete testing projects in China, and has become an industry leader, with a market share of more than 30%.

In 2020, Guangzhou Jinyu Medical Laboratory Center, a subsidiary of Jinyu Medical Group, was selected as a national-level specialized new "Little Giant" enterprise. In 2021, Golden Mile Medical was rated by msci ESG, an international authoritative index company, reaching AA level, which is the highest level in the same industry in the world.

Medical Examination Services:

"Weaving" remote collaboration network to solve the problem of pathological diagnosis

At the Pathology Diagnostic Center on the 8th floor of the Guangzhou Jinyu Medical Laboratory Center on Guangzhou International Biological Island, Dr. Chen and Dr. Wang were notified to immediately open the digital pathology picture and conduct intraoperative pathological diagnosis. At this time, the patient is still on the operating table, and the gynecologist has prepared three surgical options: only the ovarian mass is cut, one side of the ovary and fallopian tube is removed, and the bilateral ovaries and uterine bodies are removed, and the pathological diagnosis results are selected. After 3 minutes, Dr. Chen and Dr. Wang exchanged views: "Benign mature cystic teratoma. "Agree!"

When the conclusion reached the hospital, everyone breathed a sigh of relief, and the doctor continued to complete the operation according to the first set of preoperative procedures.

Such a tense and orderly scene is staged in the Golden Mile Medical Laboratory Center every day.

Golden Mile employees work in high-end laboratories.

"Pathological diagnosis is the gold standard for the diagnosis of many diseases, but there are currently only nearly 20,000 pathologists in China, which is far from meeting the clinical needs." Cheng Yating, vice president of Jinyu Medical Group, told reporters, "Jinyu has laid out a remote pathology collaboration network throughout the country, helping doctors from more than 15,000 medical institutions across the country to solve pathological diagnosis problems through a team of more than 600 pathologists and more than 300 remote support terminals." ”

Hospitals around the world will need to carry out tissue cell slice processing for pathological diagnosis, and the pictures generated by the super scanner will be transmitted to the Golden Mile system, and the pathologists in golden mile can make remote diagnosis in the laboratory, and complex cases will be consulted by multiple doctors and experts. From slice to diagnosis, the results are usually produced within half an hour, and the surgery continues according to the diagnosis results.

Cheng Yating

"This resource of pathologists has been maximally applied in Tibet." Cheng Yating explained to reporters the convenience brought by remote pathological diagnosis to patients in remote areas, "As the first third-party medical inspection institution rooted in Tibet, Tibet Jinyu has completed nearly 3,000 cases of pathological samples and more than 120 cases of remote digital pathological consultation (most of them are gynecological diseases) within one year, so that the people in Tibetan areas can enjoy the same quality of medical examination services as developed areas, and also reduce the time of travel tossing." ”

Up to now, Jinyu Medicine has carried out more than 3,000 testing projects, ranking first in the industry. Covering conventional technologies to high-end discipline platforms, it is still iteratively updating at a rate of about 200 items every year, and the annual number of detected specimens exceeds 100 million.

"Jinyu's broader vision is to be the guardian of a healthy China and a healthy sentinel of the Chinese people." Leung Yiu-ming, chairman and CEO of Jinyu Medical Group, said. The great doctor, for the country and the people, is the true portrayal of this "little giant" enterprise and its leader Liang Yaoming.

More innovation than that:

The annual research and development investment in the integrated development of production, education and research is nearly 400 million yuan

Innovation is a typical gene shared by small giant enterprises, and Jinyu has firmly engraved innovation in its bones since its birth, not only in remote pathological diagnosis, but also in testing technology innovation. After years of exploration, Jinyu has embarked on the characteristic path of integrated development of industry, education and research, and has joined hands with many scientific research institutions, universities and top experts in related disciplines to carry out cooperation in many fields. Since 2017, Jinyu Medicine has set up an academic committee, chaired by Academician Zhong Nanshan, bringing together 9 academicians and 43 top experts in various specialties such as clinical, laboratory, pathology and medical big data in medical laboratories at home and abroad, injecting new impetus into the continuous innovation of Jinyu Medicine.

Since 2008, 27 subsidiaries of Jinyu Group have been identified as national high-tech enterprises, enjoying tax incentives and R&D expense deductions and other related policies. By undertaking various types of scientific research and talent projects such as qualification recognition, platform construction, key technology research and development, and talent funding, Jinyu Medical has received financial support of more than 400 million yuan in total. At the same time, through the guidance of financial funds, Jinyu Medical Group's R&D investment in 2020 is as high as 397 million yuan, and in recent years, the annual R&D investment accounts for about 5%-7% of the sales revenue ratio, effectively improving the technical level and industrial service capabilities, and promoting the implementation of hierarchical diagnosis and treatment policies and the structural reform of the supply side of the biomedical industry.

"We always adhere to the close integration of our own cause and the cause of people's health, into the country's development trend, the future will move towards the vision of 'becoming the world's leading medical examination industry group', so that the people of China and even the world can enjoy better medical diagnosis services and have a healthy life." Cheng Yating said.

Fighting the epidemic:

Launched the "Falcon" series of laboratories, becoming a main force for nucleic acid testing

Liang Yaoming graduated from Guangzhou Medical College in 1988. At that time, the country set off a boom in colleges and universities, and Liang Yaoming also threw himself into it and started the sales business of testing reagents. Later, a college classmate inadvertently inserted a sentence that made him enlightened: "Your reagents sell so well, but you can't solve the problem of difficult testing in grass-roots hospitals, and it is difficult for me to diagnose patients when I go back to my hometown qingyuan, because there is no laboratory department in the small hospital." "Since then, Liang Yaoming has gradually seen the road to be taken in the future - to fill the gap in the domestic third-party medical testing industry." The name "Golden Mile" also means to explore this golden field that was unknown at that time.

"Small and medium-sized enterprises can do great things!" On October 24, 2018, during His inspection of Guangzhou, General Secretary Xi Jinping held a discussion with 12 representatives of heads of private enterprises and small and medium-sized enterprises, and threw out this golden and jade good word. As one of the representatives of 12 entrepreneurs, Liang Yaoming listened to the scene and was deeply encouraged.

An unexpected epidemic has allowed Jinyu to move from behind the scenes to the front of the stage. On january 24, 2020 Chinese New Year's Eve, Jinyu issued a letter to all employees, calling on all employees to enter the preparation stage. "During the Chinese New Year, the employees who participated in the fight against the epidemic pressed their fingerprints on the letters one by one, and we visited the relevant competent units one by one with the letters of invitation to persuade the government to let Jinyu go to war and take on heavy responsibilities." Cheng Yating recalled.

Over the past two years, The elite of Jinyu has done its best to resist the virus and become one of the main forces of nucleic acid testing in the country. Jinyu has also joined hands with Guangzhou Laboratory and others to innovate and launch the "Falcon" series of laboratories, including dura laboratories and mobile testing vehicles, playing a role in large-scale screening, flexible mobility and response at any time, on the one hand, to help large-scale screening in various places, on the other hand, to fully guarantee the smooth holding of major events such as the Beijing Winter Olympic Games and the Winter Paralympic Games.

Jinyu has hundreds of scientific research and testing instruments.

"Jinyu's corporate culture and service tenet can be summed up in four words: Standing on top of the sky - through medical examination technology innovation, research and development of new diagnostic technologies around the field of incurable diseases and rare diseases, for the health of the people's health 'top heaven'; at the same time, through service innovation, firmly 'stand' at the grassroots level, vigorously promote the sinking of medical inspection resources to the county and township level, so that the people can enjoy 'the same quality medical inspection services as the top three hospitals' at their doorstep, and truly practice doing practical things for the masses." Cheng Yating said.

Text/Guangzhou Daily, New Flower City Reporter: Huang Qing

Photo/ Guangzhou Daily, Xinhuacheng Reporter: Chen Youzi

Video/Guangzhou Daily Xinhuacheng Reporter: Chen Youzi Huang Qing

Guangzhou Daily Xinhuacheng Editor: Zhao Xiaoman